Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *


Products » Items » NovoSeven RT 100KIU


To avoid
As a precautionary measure

Contraindicated
NovoSeven RT 100KIU :
Type Medicine Authorised
Originator Biotech (NovoSeven RT 100KIU)
Agent Mersaco
Distributor Mersaco
Laboratory Novo Nordisk
Responsible Party Novo Nordisk AS
Origin Denmark
Manufacturer Novo Nordisk AS
Origin Denmark
ATC B02BD08

Your comment will appear shortly after approval


Different Units By MoH Code

Revision Date : 11/01/2013

NovoSeven RT 100KIU  MoH 5539 :
Form Powder and solvent for solution for injection
Packaging Pre-filled Syringes + Vials (Type I glass)
Package Size 1+1
Strength 2mg (100KIU)
Public Price 1689135 L.L.
Stratum E2
NSSF
Quarantine
Reg. Number 218018/09
Submission date 01/01/2009
Registration Year 2009





Price Comparison

Country: Italy
Package Size: 1+1x2.1ml
Public Price: 2158.24 EUR ( 209,081,658.24 LBP )
Pack size unit used: 1
Cost/Unit: 2158,24 EUR ( 209,058,408.00 LBP )
Exfactory Price: 1307.7 EUR
Pricing Date: 17/12/2019
Type: Medicine Authorised

Country: Qatar
Package Size: 1
Public Price: 7927 QAR ( 194,671,266.00 LBP )
Pack size unit used: 1
Cost/Unit: 7927 QAR ( 194,671,266.00 LBP )
Pharmacy Price: 6510.94417298 QAR ( 159895767.00004 LBP )
Pricing Date: 28/01/2021
Type: Medicine Authorised

Country: Oman
Package Size: 1+1
Public Price: 834.57 OMR ( 192,563,674.38 LBP )
Pack size unit used: 1
Cost/Unit: 834,57 OMR ( 192,432,156.00 LBP )
Pricing Date: 19/02/2021
Type: Medicine Authorised

Country: Kuweit
Package Size: 1+1
Public Price: 638.4 KWD ( 187,422,110.40 LBP )
Pack size unit used: 1
Cost/Unit: 638,4 KWD ( 187,304,678.00 LBP )
Pharmacy Price: 539.34 KWD ( 158339976.54 LBP )
Pricing Date: 07/02/2021
Type: Medicine Authorised

Country: Switzerland
Package Size: 1+1
Public Price: 1774.15 CHF ( 183,482,593.00 LBP )
Pack size unit used: 1
Cost/Unit: 1774,15 CHF ( 183,467,080.00 LBP )
Exfactory Price: 1690.88 CHF
Pricing Date: 04/04/2021
Type: Medicine Authorised

Country: Abu Dhabi
Package Size: 1+1x2.1ml
Public Price: 7406.5 AED ( 178,948,446.50 LBP )
Pack size unit used: 1
Cost/Unit: 7406,5 AED ( 178,936,366.00 LBP )
Pharmacy Price: 6309.52 AED ( 152444312.72 LBP )
Pricing Date: 27/01/2021
Type: Medicine Authorised

Country: UAE
Package Size: 1 Vial (Powder) + 1 Solvent Vial (2.1ml)
Public Price: 7406.5 AED ( 178,948,446.50 LBP )
Pack size unit used: 1
Cost/Unit: 7406,5 AED ( 178,936,366.00 LBP )
Pharmacy Price: 6309.52 AED ( 152444312.72 LBP )
Pricing Date: 21/08/2019
Type: Medicine Authorised

Country: Bahrain
Package Size: 1+1
Public Price: 704.5 BHD ( 167,483,603.00 LBP )
Pack size unit used: 1
Cost/Unit: 704,5 BHD ( 167,364,736.00 LBP )
Reference: nhra
Pricing Date: 09/02/2021
Type: Medicine Authorised

Country: Finland
Package Size: 1+1x2ml
Public Price: 1579.45 EUR ( 153,010,798.20 LBP )
Pack size unit used: 1
Cost/Unit: 1579,45 EUR ( 152,967,204.00 LBP )
Reference: Kela
Pricing Date: 22/04/2021
Type: Medicine Authorised

Country: Iceland
Package Size: 1+1
Public Price: 216970 ISK ( 139,945,650.00 LBP )
Pack size unit used: 1
Cost/Unit: 216970 ISK ( 139,945,650.00 LBP )
Pharmacy Price: 169345 ISK ( 109227525 LBP )
Reference: Icelandic Medicines Agency
Pricing Date: 01/04/2020
Type: Medicine Authorised

Country: Denmark
Package Size: 1+1
Public Price: 10629.4 DKK ( 137,927,094.40 LBP )
Pack size unit used: 1
Cost/Unit: 10629,4 DKK ( 137,921,904.00 LBP )
Pharmacy Price: 7897.84 DKK ( 102482371.84 LBP )
Reference: Danish Medicine Agency
Pricing Date: 19/05/2021
Type: Medicine Authorised

Country: Czech Republic
Package Size: 1+1x2ml
Public Price: 34221.93 CZK ( 130,693,550.67 LBP )
Pack size unit used: 1
Cost/Unit: 34221,93 CZK ( 130,689,999.00 LBP )
Reference: SUKL
Pricing Date: 28/02/2020
Type: Medicine Authorised

Country: KSA
Package Size: 2mg
Public Price: 5290.4 SAR ( 125,065,056.00 LBP )
Pack size unit used: 1
Cost/Unit: 5290,4 SAR ( 125,055,600.00 LBP )
Reference: sfda
Pricing Date: 16/01/2021
Type: Medicine Authorised

Country: Cyprus
Package Size: 1 x 2ml
Public Price: 1263.97 EUR ( 122,448,357.72 LBP )
Pack size unit used: 1
Cost/Unit: 1263,97 EUR ( 122,354,388.00 LBP )
Reference: Cyprus Minister of Health
Pricing Date: 24/03/2021
Type: Medicine Authorised

Country: Greece
Package Size: 1+1
Public Price: 1260.19 EUR ( 122,082,166.44 LBP )
Pack size unit used: 1
Cost/Unit: 1260,19 EUR ( 122,063,760.00 LBP )
Exfactory Price: 1115.49 EUR
Pharmacy Price: 1132.25 EUR ( 109687851 LBP )
Reference: National Organization for Medicines
Pricing Date: 25/02/2021
Type: Medicine Authorised

Country: UK
Package Size: 1+1
Public Price: 1050.4 GBP ( 119,376,909.60 LBP )
Pack size unit used: 1
Cost/Unit: 1050,4 GBP ( 119,331,450.00 LBP )
Reference: DMD
Pricing Date: 08/03/2021
Type: Medicine Authorised

Country: Spain
Package Size: 1 vial + 1xdisolvente
Public Price: 1220.48 EUR ( 118,235,220.48 LBP )
Pack size unit used: 1
Cost/Unit: 1220,48 EUR ( 118,188,720.00 LBP )
Reference: Agencia Española de Medicamentos y Productos Sanitarios
Pricing Date: 06/05/2021
Type: Medicine Non Marketed

Country: France
Package Size: 1+1
Public Price: 1216 EUR ( 117,801,216.00 LBP )
Pack size unit used: 1
Cost/Unit: 1216 EUR ( 117,801,216.00 LBP )
Reference: ansm
Pricing Date: 15/05/2021
Type: Medicine Authorised

Country: Belgium
Package Size: 1+1x2.1ml
Public Price: 1065 EUR ( 103,172,940.00 LBP )
Pack size unit used: 1
Cost/Unit: 1065 EUR ( 103,172,940.00 LBP )
Reference: cbip
Pricing Date: 02/12/2020
Type: Medicine Authorised

Country: Norway
Package Size: 1
Public Price: 12060.5 NOK ( 97,738,292.00 LBP )
Pack size unit used: 1
Cost/Unit: 12060,5 NOK ( 97,734,240.00 LBP )
Pharmacy Price: 9430.82 NOK ( 76427365.28 LBP )
Reference: Norwegian Medicine Agency
Pricing Date: 01/04/2020
Type: Medicine Authorised

Country: Sweden
Package Size: 1+1
Public Price: 11420.85 SEK ( 96,026,506.80 LBP )
Pack size unit used: 1
Cost/Unit: 11420,85 SEK ( 96,019,360.00 LBP )
Pharmacy Price: 11151.57 SEK ( 93762400.56 LBP )
Pricing Date: 23/04/2020
Type: Medicine Authorised

Country: Turkey
Package Size: 1
Public Price: 5801.16 TRY ( 15,547,108.80 LBP )
Pack size unit used: 1
Cost/Unit: 5801,16 TRY ( 15,546,680.00 LBP )
Pricing Date: 28/10/2020
Type: Medicine Authorised

Country: Lebanon
Form: Powder and solvent for solution for injection
Package Size: 1+1
Public Price: 1689135 LBP ( 1,689,135.00 LBP )
Pack size unit used: 1
Cost/Unit: 1689135 LBP ( 1,689,135.00 LBP )
Pricing Date: 13/06/2024

Country: The Netherlands
Package Size: 1
Reference: Zorginstituut Nederland
Pricing Date: 15/06/2019
Type: Medicine Non Marketed

Country: New Zealand
Package Size: 1 inj
Exfactory Price: 2356.6 NZD
Reference: New Zealand Pharmaceutical Management Agency
Pricing Date: 01/04/2020
Type: Medicine Authorised

Country: Portugal
Package Size: 1+1
Reference: Autoridade Nacional do Medicamento e Produtos de Saúde
Pricing Date: 22/04/2019

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries


Note

Acquired haemophilia :
Cost/Unit: 2158,24 EUR ( 209,058,408.00 LBP )
Cost/Day: 6474,72 EUR ( 627,175,224.00 LBP )
Cost/Month: 6474,72 EUR ( 627,175,224.00 LBP )
Congenital FVII deficiency :
Cost/Unit: 2158,24 EUR ( 209,058,408.00 LBP )
Cost/Day: 6474,72 EUR ( 627,175,224.00 LBP )
Cost/Month: 6474,72 EUR ( 627,175,224.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
Cost/Unit: 2158,24 EUR ( 209,058,408.00 LBP )
Cost/Day: 6474,72 EUR ( 627,175,224.00 LBP )
Cost/Month: 6474,72 EUR ( 627,175,224.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
Cost/Unit: 2158,24 EUR ( 209,058,408.00 LBP )
Cost/Day: 6474,72 EUR ( 627,175,224.00 LBP )
Cost/Month: 6474,72 EUR ( 627,175,224.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA : (Adults)
Cost/Unit: 2158,24 EUR ( 209,058,408.00 LBP )
Cost/Day: 6474,72 EUR ( 627,175,224.00 LBP )
Cost/Month: 6474,72 EUR ( 627,175,224.00 LBP )
Acquired haemophilia :
Cost/Unit: 7927 QAR ( 194,671,266.00 LBP )
Cost/Day: 23781 QAR ( 584,013,798.00 LBP )
Cost/Month: 23781 QAR ( 584,013,798.00 LBP )
Congenital FVII deficiency :
Cost/Unit: 7927 QAR ( 194,671,266.00 LBP )
Cost/Day: 23781 QAR ( 584,013,798.00 LBP )
Cost/Month: 23781 QAR ( 584,013,798.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
Cost/Unit: 7927 QAR ( 194,671,266.00 LBP )
Cost/Day: 23781 QAR ( 584,013,798.00 LBP )
Cost/Month: 23781 QAR ( 584,013,798.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
Cost/Unit: 7927 QAR ( 194,671,266.00 LBP )
Cost/Day: 23781 QAR ( 584,013,798.00 LBP )
Cost/Month: 23781 QAR ( 584,013,798.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA : (Adults)
Cost/Unit: 7927 QAR ( 194,671,266.00 LBP )
Cost/Day: 23781 QAR ( 584,013,798.00 LBP )
Cost/Month: 23781 QAR ( 584,013,798.00 LBP )
Acquired haemophilia :
Cost/Unit: 834,57 OMR ( 192,432,156.00 LBP )
Cost/Day: 2503,71 OMR ( 577,527,202.00 LBP )
Cost/Month: 2503,71 OMR ( 577,527,202.00 LBP )
Congenital FVII deficiency :
Cost/Unit: 834,57 OMR ( 192,432,156.00 LBP )
Cost/Day: 2503,71 OMR ( 577,527,202.00 LBP )
Cost/Month: 2503,71 OMR ( 577,527,202.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
Cost/Unit: 834,57 OMR ( 192,432,156.00 LBP )
Cost/Day: 2503,71 OMR ( 577,527,202.00 LBP )
Cost/Month: 2503,71 OMR ( 577,527,202.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
Cost/Unit: 834,57 OMR ( 192,432,156.00 LBP )
Cost/Day: 2503,71 OMR ( 577,527,202.00 LBP )
Cost/Month: 2503,71 OMR ( 577,527,202.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA : (Adults)
Cost/Unit: 834,57 OMR ( 192,432,156.00 LBP )
Cost/Day: 2503,71 OMR ( 577,527,202.00 LBP )
Cost/Month: 2503,71 OMR ( 577,527,202.00 LBP )
Acquired haemophilia :
Cost/Unit: 638,4 KWD ( 187,304,678.00 LBP )
Cost/Day: 1915,2 KWD ( 562,207,615.00 LBP )
Cost/Month: 1915,2 KWD ( 562,207,615.00 LBP )
Congenital FVII deficiency :
Cost/Unit: 638,4 KWD ( 187,304,678.00 LBP )
Cost/Day: 1915,2 KWD ( 562,207,615.00 LBP )
Cost/Month: 1915,2 KWD ( 562,207,615.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
Cost/Unit: 638,4 KWD ( 187,304,678.00 LBP )
Cost/Day: 1915,2 KWD ( 562,207,615.00 LBP )
Cost/Month: 1915,2 KWD ( 562,207,615.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
Cost/Unit: 638,4 KWD ( 187,304,678.00 LBP )
Cost/Day: 1915,2 KWD ( 562,207,615.00 LBP )
Cost/Month: 1915,2 KWD ( 562,207,615.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA : (Adults)
Cost/Unit: 638,4 KWD ( 187,304,678.00 LBP )
Cost/Day: 1915,2 KWD ( 562,207,615.00 LBP )
Cost/Month: 1915,2 KWD ( 562,207,615.00 LBP )
Acquired haemophilia :
Cost/Unit: 1774,15 CHF ( 183,467,080.00 LBP )
Cost/Day: 5322,45 CHF ( 550,401,240.00 LBP )
Cost/Month: 5322,45 CHF ( 550,401,240.00 LBP )
Congenital FVII deficiency :
Cost/Unit: 1774,15 CHF ( 183,467,080.00 LBP )
Cost/Day: 5322,45 CHF ( 550,401,240.00 LBP )
Cost/Month: 5322,45 CHF ( 550,401,240.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
Cost/Unit: 1774,15 CHF ( 183,467,080.00 LBP )
Cost/Day: 5322,45 CHF ( 550,401,240.00 LBP )
Cost/Month: 5322,45 CHF ( 550,401,240.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
Cost/Unit: 1774,15 CHF ( 183,467,080.00 LBP )
Cost/Day: 5322,45 CHF ( 550,401,240.00 LBP )
Cost/Month: 5322,45 CHF ( 550,401,240.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA : (Adults)
Cost/Unit: 1774,15 CHF ( 183,467,080.00 LBP )
Cost/Day: 5322,45 CHF ( 550,401,240.00 LBP )
Cost/Month: 5322,45 CHF ( 550,401,240.00 LBP )
Acquired haemophilia :
Cost/Unit: 7406,5 AED ( 178,936,366.00 LBP )
Cost/Day: 22219,5 AED ( 536,833,259.00 LBP )
Cost/Month: 22219,5 AED ( 536,833,259.00 LBP )
Congenital FVII deficiency :
Cost/Unit: 7406,5 AED ( 178,936,366.00 LBP )
Cost/Day: 22219,5 AED ( 536,833,259.00 LBP )
Cost/Month: 22219,5 AED ( 536,833,259.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
Cost/Unit: 7406,5 AED ( 178,936,366.00 LBP )
Cost/Day: 22219,5 AED ( 536,833,259.00 LBP )
Cost/Month: 22219,5 AED ( 536,833,259.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
Cost/Unit: 7406,5 AED ( 178,936,366.00 LBP )
Cost/Day: 22219,5 AED ( 536,833,259.00 LBP )
Cost/Month: 22219,5 AED ( 536,833,259.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA : (Adults)
Cost/Unit: 7406,5 AED ( 178,936,366.00 LBP )
Cost/Day: 22219,5 AED ( 536,833,259.00 LBP )
Cost/Month: 22219,5 AED ( 536,833,259.00 LBP )
Acquired haemophilia :
Cost/Unit: 7406,5 AED ( 178,936,366.00 LBP )
Cost/Day: 22219,5 AED ( 536,833,259.00 LBP )
Cost/Month: 22219,5 AED ( 536,833,259.00 LBP )
Congenital FVII deficiency :
Cost/Unit: 7406,5 AED ( 178,936,366.00 LBP )
Cost/Day: 22219,5 AED ( 536,833,259.00 LBP )
Cost/Month: 22219,5 AED ( 536,833,259.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
Cost/Unit: 7406,5 AED ( 178,936,366.00 LBP )
Cost/Day: 22219,5 AED ( 536,833,259.00 LBP )
Cost/Month: 22219,5 AED ( 536,833,259.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
Cost/Unit: 7406,5 AED ( 178,936,366.00 LBP )
Cost/Day: 22219,5 AED ( 536,833,259.00 LBP )
Cost/Month: 22219,5 AED ( 536,833,259.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA : (Adults)
Cost/Unit: 7406,5 AED ( 178,936,366.00 LBP )
Cost/Day: 22219,5 AED ( 536,833,259.00 LBP )
Cost/Month: 22219,5 AED ( 536,833,259.00 LBP )
Acquired haemophilia :
Cost/Unit: 704,5 BHD ( 167,364,736.00 LBP )
Cost/Day: 2113,5 BHD ( 502,331,942.00 LBP )
Cost/Month: 2113,5 BHD ( 502,331,942.00 LBP )
Congenital FVII deficiency :
Cost/Unit: 704,5 BHD ( 167,364,736.00 LBP )
Cost/Day: 2113,5 BHD ( 502,331,942.00 LBP )
Cost/Month: 2113,5 BHD ( 502,331,942.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
Cost/Unit: 704,5 BHD ( 167,364,736.00 LBP )
Cost/Day: 2113,5 BHD ( 502,331,942.00 LBP )
Cost/Month: 2113,5 BHD ( 502,331,942.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
Cost/Unit: 704,5 BHD ( 167,364,736.00 LBP )
Cost/Day: 2113,5 BHD ( 502,331,942.00 LBP )
Cost/Month: 2113,5 BHD ( 502,331,942.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA : (Adults)
Cost/Unit: 704,5 BHD ( 167,364,736.00 LBP )
Cost/Day: 2113,5 BHD ( 502,331,942.00 LBP )
Cost/Month: 2113,5 BHD ( 502,331,942.00 LBP )
Acquired haemophilia :
Cost/Unit: 1579,45 EUR ( 152,967,204.00 LBP )
Cost/Day: 4738,35 EUR ( 458,998,488.00 LBP )
Cost/Month: 4738,35 EUR ( 458,998,488.00 LBP )
Congenital FVII deficiency :
Cost/Unit: 1579,45 EUR ( 152,967,204.00 LBP )
Cost/Day: 4738,35 EUR ( 458,998,488.00 LBP )
Cost/Month: 4738,35 EUR ( 458,998,488.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
Cost/Unit: 1579,45 EUR ( 152,967,204.00 LBP )
Cost/Day: 4738,35 EUR ( 458,998,488.00 LBP )
Cost/Month: 4738,35 EUR ( 458,998,488.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
Cost/Unit: 1579,45 EUR ( 152,967,204.00 LBP )
Cost/Day: 4738,35 EUR ( 458,998,488.00 LBP )
Cost/Month: 4738,35 EUR ( 458,998,488.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA : (Adults)
Cost/Unit: 1579,45 EUR ( 152,967,204.00 LBP )
Cost/Day: 4738,35 EUR ( 458,998,488.00 LBP )
Cost/Month: 4738,35 EUR ( 458,998,488.00 LBP )
Acquired haemophilia :
Cost/Unit: 216970 ISK ( 139,945,650.00 LBP )
Cost/Day: 650910 ISK ( 419,836,950.00 LBP )
Cost/Month: 650910 ISK ( 419,836,950.00 LBP )
Congenital FVII deficiency :
Cost/Unit: 216970 ISK ( 139,945,650.00 LBP )
Cost/Day: 650910 ISK ( 419,836,950.00 LBP )
Cost/Month: 650910 ISK ( 419,836,950.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
Cost/Unit: 216970 ISK ( 139,945,650.00 LBP )
Cost/Day: 650910 ISK ( 419,836,950.00 LBP )
Cost/Month: 650910 ISK ( 419,836,950.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
Cost/Unit: 216970 ISK ( 139,945,650.00 LBP )
Cost/Day: 650910 ISK ( 419,836,950.00 LBP )
Cost/Month: 650910 ISK ( 419,836,950.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA : (Adults)
Cost/Unit: 216970 ISK ( 139,945,650.00 LBP )
Cost/Day: 650910 ISK ( 419,836,950.00 LBP )
Cost/Month: 650910 ISK ( 419,836,950.00 LBP )
Acquired haemophilia :
Cost/Unit: 10629,4 DKK ( 137,921,904.00 LBP )
Cost/Day: 31888,2 DKK ( 413,778,688.00 LBP )
Cost/Month: 31888,2 DKK ( 413,778,688.00 LBP )
Congenital FVII deficiency :
Cost/Unit: 10629,4 DKK ( 137,921,904.00 LBP )
Cost/Day: 31888,2 DKK ( 413,778,688.00 LBP )
Cost/Month: 31888,2 DKK ( 413,778,688.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
Cost/Unit: 10629,4 DKK ( 137,921,904.00 LBP )
Cost/Day: 31888,2 DKK ( 413,778,688.00 LBP )
Cost/Month: 31888,2 DKK ( 413,778,688.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
Cost/Unit: 10629,4 DKK ( 137,921,904.00 LBP )
Cost/Day: 31888,2 DKK ( 413,778,688.00 LBP )
Cost/Month: 31888,2 DKK ( 413,778,688.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA : (Adults)
Cost/Unit: 10629,4 DKK ( 137,921,904.00 LBP )
Cost/Day: 31888,2 DKK ( 413,778,688.00 LBP )
Cost/Month: 31888,2 DKK ( 413,778,688.00 LBP )
Acquired haemophilia :
Cost/Unit: 34221,93 CZK ( 130,689,999.00 LBP )
Cost/Day: 102665,79 CZK ( 392,077,635.00 LBP )
Cost/Month: 102665,79 CZK ( 392,077,635.00 LBP )
Congenital FVII deficiency :
Cost/Unit: 34221,93 CZK ( 130,689,999.00 LBP )
Cost/Day: 102665,79 CZK ( 392,077,635.00 LBP )
Cost/Month: 102665,79 CZK ( 392,077,635.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
Cost/Unit: 34221,93 CZK ( 130,689,999.00 LBP )
Cost/Day: 102665,79 CZK ( 392,077,635.00 LBP )
Cost/Month: 102665,79 CZK ( 392,077,635.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
Cost/Unit: 34221,93 CZK ( 130,689,999.00 LBP )
Cost/Day: 102665,79 CZK ( 392,077,635.00 LBP )
Cost/Month: 102665,79 CZK ( 392,077,635.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA : (Adults)
Cost/Unit: 34221,93 CZK ( 130,689,999.00 LBP )
Cost/Day: 102665,79 CZK ( 392,077,635.00 LBP )
Cost/Month: 102665,79 CZK ( 392,077,635.00 LBP )
Acquired haemophilia :
Cost/Unit: 5290,4 SAR ( 125,055,600.00 LBP )
Cost/Day: 15871,2 SAR ( 375,190,440.00 LBP )
Cost/Month: 15871,2 SAR ( 375,190,440.00 LBP )
Congenital FVII deficiency :
Cost/Unit: 5290,4 SAR ( 125,055,600.00 LBP )
Cost/Day: 15871,2 SAR ( 375,190,440.00 LBP )
Cost/Month: 15871,2 SAR ( 375,190,440.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
Cost/Unit: 5290,4 SAR ( 125,055,600.00 LBP )
Cost/Day: 15871,2 SAR ( 375,190,440.00 LBP )
Cost/Month: 15871,2 SAR ( 375,190,440.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
Cost/Unit: 5290,4 SAR ( 125,055,600.00 LBP )
Cost/Day: 15871,2 SAR ( 375,190,440.00 LBP )
Cost/Month: 15871,2 SAR ( 375,190,440.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA : (Adults)
Cost/Unit: 5290,4 SAR ( 125,055,600.00 LBP )
Cost/Day: 15871,2 SAR ( 375,190,440.00 LBP )
Cost/Month: 15871,2 SAR ( 375,190,440.00 LBP )
Acquired haemophilia :
Cost/Unit: 1263,97 EUR ( 122,354,388.00 LBP )
Cost/Day: 3791,91 EUR ( 367,256,916.00 LBP )
Cost/Month: 3791,91 EUR ( 367,256,916.00 LBP )
Congenital FVII deficiency :
Cost/Unit: 1263,97 EUR ( 122,354,388.00 LBP )
Cost/Day: 3791,91 EUR ( 367,256,916.00 LBP )
Cost/Month: 3791,91 EUR ( 367,256,916.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
Cost/Unit: 1263,97 EUR ( 122,354,388.00 LBP )
Cost/Day: 3791,91 EUR ( 367,256,916.00 LBP )
Cost/Month: 3791,91 EUR ( 367,256,916.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
Cost/Unit: 1263,97 EUR ( 122,354,388.00 LBP )
Cost/Day: 3791,91 EUR ( 367,256,916.00 LBP )
Cost/Month: 3791,91 EUR ( 367,256,916.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA : (Adults)
Cost/Unit: 1263,97 EUR ( 122,354,388.00 LBP )
Cost/Day: 3791,91 EUR ( 367,256,916.00 LBP )
Cost/Month: 3791,91 EUR ( 367,256,916.00 LBP )
Acquired haemophilia :
Cost/Unit: 1260,19 EUR ( 122,063,760.00 LBP )
Cost/Day: 3780,57 EUR ( 366,191,280.00 LBP )
Cost/Month: 3780,57 EUR ( 366,191,280.00 LBP )
Congenital FVII deficiency :
Cost/Unit: 1260,19 EUR ( 122,063,760.00 LBP )
Cost/Day: 3780,57 EUR ( 366,191,280.00 LBP )
Cost/Month: 3780,57 EUR ( 366,191,280.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
Cost/Unit: 1260,19 EUR ( 122,063,760.00 LBP )
Cost/Day: 3780,57 EUR ( 366,191,280.00 LBP )
Cost/Month: 3780,57 EUR ( 366,191,280.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
Cost/Unit: 1260,19 EUR ( 122,063,760.00 LBP )
Cost/Day: 3780,57 EUR ( 366,191,280.00 LBP )
Cost/Month: 3780,57 EUR ( 366,191,280.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA : (Adults)
Cost/Unit: 1260,19 EUR ( 122,063,760.00 LBP )
Cost/Day: 3780,57 EUR ( 366,191,280.00 LBP )
Cost/Month: 3780,57 EUR ( 366,191,280.00 LBP )
Acquired haemophilia :
Cost/Unit: 1050,4 GBP ( 119,331,450.00 LBP )
Cost/Day: 3151,2 GBP ( 358,107,999.00 LBP )
Cost/Month: 3151,2 GBP ( 358,107,999.00 LBP )
Congenital FVII deficiency :
Cost/Unit: 1050,4 GBP ( 119,331,450.00 LBP )
Cost/Day: 3151,2 GBP ( 358,107,999.00 LBP )
Cost/Month: 3151,2 GBP ( 358,107,999.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
Cost/Unit: 1050,4 GBP ( 119,331,450.00 LBP )
Cost/Day: 3151,2 GBP ( 358,107,999.00 LBP )
Cost/Month: 3151,2 GBP ( 358,107,999.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
Cost/Unit: 1050,4 GBP ( 119,331,450.00 LBP )
Cost/Day: 3151,2 GBP ( 358,107,999.00 LBP )
Cost/Month: 3151,2 GBP ( 358,107,999.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA : (Adults)
Cost/Unit: 1050,4 GBP ( 119,331,450.00 LBP )
Cost/Day: 3151,2 GBP ( 358,107,999.00 LBP )
Cost/Month: 3151,2 GBP ( 358,107,999.00 LBP )
Acquired haemophilia :
Cost/Unit: 1220,48 EUR ( 118,188,720.00 LBP )
Cost/Day: 3661,44 EUR ( 354,663,036.00 LBP )
Cost/Month: 3661,44 EUR ( 354,663,036.00 LBP )
Congenital FVII deficiency :
Cost/Unit: 1220,48 EUR ( 118,188,720.00 LBP )
Cost/Day: 3661,44 EUR ( 354,663,036.00 LBP )
Cost/Month: 3661,44 EUR ( 354,663,036.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
Cost/Unit: 1220,48 EUR ( 118,188,720.00 LBP )
Cost/Day: 3661,44 EUR ( 354,663,036.00 LBP )
Cost/Month: 3661,44 EUR ( 354,663,036.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
Cost/Unit: 1220,48 EUR ( 118,188,720.00 LBP )
Cost/Day: 3661,44 EUR ( 354,663,036.00 LBP )
Cost/Month: 3661,44 EUR ( 354,663,036.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA : (Adults)
Cost/Unit: 1220,48 EUR ( 118,188,720.00 LBP )
Cost/Day: 3661,44 EUR ( 354,663,036.00 LBP )
Cost/Month: 3661,44 EUR ( 354,663,036.00 LBP )
Acquired haemophilia :
Cost/Unit: 1216 EUR ( 117,801,216.00 LBP )
Cost/Day: 3648 EUR ( 353,403,648.00 LBP )
Cost/Month: 3648 EUR ( 353,403,648.00 LBP )
Congenital FVII deficiency :
Cost/Unit: 1216 EUR ( 117,801,216.00 LBP )
Cost/Day: 3648 EUR ( 353,403,648.00 LBP )
Cost/Month: 3648 EUR ( 353,403,648.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
Cost/Unit: 1216 EUR ( 117,801,216.00 LBP )
Cost/Day: 3648 EUR ( 353,403,648.00 LBP )
Cost/Month: 3648 EUR ( 353,403,648.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
Cost/Unit: 1216 EUR ( 117,801,216.00 LBP )
Cost/Day: 3648 EUR ( 353,403,648.00 LBP )
Cost/Month: 3648 EUR ( 353,403,648.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA : (Adults)
Cost/Unit: 1216 EUR ( 117,801,216.00 LBP )
Cost/Day: 3648 EUR ( 353,403,648.00 LBP )
Cost/Month: 3648 EUR ( 353,403,648.00 LBP )
Acquired haemophilia :
Cost/Unit: 1065 EUR ( 103,172,940.00 LBP )
Cost/Day: 3195 EUR ( 309,518,820.00 LBP )
Cost/Month: 3195 EUR ( 309,518,820.00 LBP )
Congenital FVII deficiency :
Cost/Unit: 1065 EUR ( 103,172,940.00 LBP )
Cost/Day: 3195 EUR ( 309,518,820.00 LBP )
Cost/Month: 3195 EUR ( 309,518,820.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
Cost/Unit: 1065 EUR ( 103,172,940.00 LBP )
Cost/Day: 3195 EUR ( 309,518,820.00 LBP )
Cost/Month: 3195 EUR ( 309,518,820.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
Cost/Unit: 1065 EUR ( 103,172,940.00 LBP )
Cost/Day: 3195 EUR ( 309,518,820.00 LBP )
Cost/Month: 3195 EUR ( 309,518,820.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA : (Adults)
Cost/Unit: 1065 EUR ( 103,172,940.00 LBP )
Cost/Day: 3195 EUR ( 309,518,820.00 LBP )
Cost/Month: 3195 EUR ( 309,518,820.00 LBP )
Acquired haemophilia :
Cost/Unit: 12060,5 NOK ( 97,734,240.00 LBP )
Cost/Day: 36181,5 NOK ( 293,210,824.00 LBP )
Cost/Month: 36181,5 NOK ( 293,210,824.00 LBP )
Congenital FVII deficiency :
Cost/Unit: 12060,5 NOK ( 97,734,240.00 LBP )
Cost/Day: 36181,5 NOK ( 293,210,824.00 LBP )
Cost/Month: 36181,5 NOK ( 293,210,824.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
Cost/Unit: 12060,5 NOK ( 97,734,240.00 LBP )
Cost/Day: 36181,5 NOK ( 293,210,824.00 LBP )
Cost/Month: 36181,5 NOK ( 293,210,824.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
Cost/Unit: 12060,5 NOK ( 97,734,240.00 LBP )
Cost/Day: 36181,5 NOK ( 293,210,824.00 LBP )
Cost/Month: 36181,5 NOK ( 293,210,824.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA : (Adults)
Cost/Unit: 12060,5 NOK ( 97,734,240.00 LBP )
Cost/Day: 36181,5 NOK ( 293,210,824.00 LBP )
Cost/Month: 36181,5 NOK ( 293,210,824.00 LBP )
Acquired haemophilia :
Cost/Unit: 11420,85 SEK ( 96,019,360.00 LBP )
Cost/Day: 34262,55 SEK ( 288,074,896.00 LBP )
Cost/Month: 34262,55 SEK ( 288,074,896.00 LBP )
Congenital FVII deficiency :
Cost/Unit: 11420,85 SEK ( 96,019,360.00 LBP )
Cost/Day: 34262,55 SEK ( 288,074,896.00 LBP )
Cost/Month: 34262,55 SEK ( 288,074,896.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
Cost/Unit: 11420,85 SEK ( 96,019,360.00 LBP )
Cost/Day: 34262,55 SEK ( 288,074,896.00 LBP )
Cost/Month: 34262,55 SEK ( 288,074,896.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
Cost/Unit: 11420,85 SEK ( 96,019,360.00 LBP )
Cost/Day: 34262,55 SEK ( 288,074,896.00 LBP )
Cost/Month: 34262,55 SEK ( 288,074,896.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA : (Adults)
Cost/Unit: 11420,85 SEK ( 96,019,360.00 LBP )
Cost/Day: 34262,55 SEK ( 288,074,896.00 LBP )
Cost/Month: 34262,55 SEK ( 288,074,896.00 LBP )
Acquired haemophilia :
Cost/Unit: 5801,16 TRY ( 15,546,680.00 LBP )
Cost/Day: 17403,48 TRY ( 46,640,040.00 LBP )
Cost/Month: 17403,48 TRY ( 46,640,040.00 LBP )
Congenital FVII deficiency :
Cost/Unit: 5801,16 TRY ( 15,546,680.00 LBP )
Cost/Day: 17403,48 TRY ( 46,640,040.00 LBP )
Cost/Month: 17403,48 TRY ( 46,640,040.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
Cost/Unit: 5801,16 TRY ( 15,546,680.00 LBP )
Cost/Day: 17403,48 TRY ( 46,640,040.00 LBP )
Cost/Month: 17403,48 TRY ( 46,640,040.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
Cost/Unit: 5801,16 TRY ( 15,546,680.00 LBP )
Cost/Day: 17403,48 TRY ( 46,640,040.00 LBP )
Cost/Month: 17403,48 TRY ( 46,640,040.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA : (Adults)
Cost/Unit: 5801,16 TRY ( 15,546,680.00 LBP )
Cost/Day: 17403,48 TRY ( 46,640,040.00 LBP )
Cost/Month: 17403,48 TRY ( 46,640,040.00 LBP )
Acquired haemophilia :
Cost/Unit: 1689135 LBP ( 1,689,135.00 LBP )
Cost/Day: 5067405 LBP ( 5,067,405.00 LBP )
Cost/Month: 5067405 LBP ( 5,067,405.00 LBP )
Congenital FVII deficiency :
Cost/Unit: 1689135 LBP ( 1,689,135.00 LBP )
Cost/Day: 5067405 LBP ( 5,067,405.00 LBP )
Cost/Month: 5067405 LBP ( 5,067,405.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
Cost/Unit: 1689135 LBP ( 1,689,135.00 LBP )
Cost/Day: 5067405 LBP ( 5,067,405.00 LBP )
Cost/Month: 5067405 LBP ( 5,067,405.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
Cost/Unit: 1689135 LBP ( 1,689,135.00 LBP )
Cost/Day: 5067405 LBP ( 5,067,405.00 LBP )
Cost/Month: 5067405 LBP ( 5,067,405.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA : (Adults)
Cost/Unit: 1689135 LBP ( 1,689,135.00 LBP )
Cost/Day: 5067405 LBP ( 5,067,405.00 LBP )
Cost/Month: 5067405 LBP ( 5,067,405.00 LBP )

Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info